KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Asset Writedowns and Impairment (2016 - 2023)

Merck has reported Asset Writedowns and Impairment over the past 14 years, most recently at $779.0 million for Q4 2023.

  • Quarterly Asset Writedowns and Impairment fell 7.15% to $779.0 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $2.8 billion through Dec 2023, up 38.41% year-over-year, with the annual reading at $55.0 million for FY2025, 41.03% up from the prior year.
  • Asset Writedowns and Impairment was $779.0 million for Q4 2023 at Merck, down from $839.0 million in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $1.7 billion in Q4 2020 and troughed at $15.0 million in Q3 2020.
  • The 5-year median for Asset Writedowns and Impairment is $302.0 million (2021), against an average of $505.9 million.
  • The largest YoY upside for Asset Writedowns and Impairment was 856.25% in 2020 against a maximum downside of 97.55% in 2020.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $176.0 million in 2019, then surged by 856.25% to $1.7 billion in 2020, then tumbled by 82.06% to $302.0 million in 2021, then soared by 177.81% to $839.0 million in 2022, then decreased by 7.15% to $779.0 million in 2023.
  • Per Business Quant, the three most recent readings for MRK's Asset Writedowns and Impairment are $779.0 million (Q4 2023), $839.0 million (Q4 2022), and $887.0 million (Q3 2022).